<DOC>
	<DOCNO>NCT02715115</DOCNO>
	<brief_summary>The purpose study determine whether NNZ-2566 safe well tolerate treatment Rett syndrome child adolescent .</brief_summary>
	<brief_title>A Safety Study NNZ-2566 Pediatric Rett Syndrome</brief_title>
	<detailed_description>Rett syndrome neurodevelopmental disorder primarily affect female . The disorder characterize apparent normal development early infancy ( 6-18 month ) , follow period regression onset systemic neurological sign . The CNS symptom Rett syndrome include learn disability , autism symptomatology epilepsy severe highly debilitate . Affected individual also show sign autonomic dysfunction , reflect cardiovascular respiratory abnormality . There currently effective treatment Rett syndrome . This study investigate safety , tolerability blood pharmacokinetics treatment oral administration NNZ-2566 50 mg/kg , 100 mg/kg , 200 mg/kg BID , placebo BID , child adolescent female Rett syndrome . The study also also investigate measure efficacy biomarkers treatment .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Rett Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Diagnosis classic/typical Rett syndrome document mutation MeCP2 gene . Age 5 15 year . Weight Screening Baseline 15.0 kg100.0 kg ( least 15.0 kg great 100.0 kg ) . Each subject must able swallow study medication provide liquid solution , via gastrostomy tube . Actively undergoing neurological regression Abnormal QT interval , prolongation significant cardiovascular history . Current treatment insulin . Anticonvulsants liver enzyme inducing effect . Unstable seizure profile . Excluded concomitant medication . Current clinically significant ( determined investigator ) . cardiovascular , renal , hepatic , respiratory disease . Gastrointestinal disease may interfere absorption , distribution , metabolism excretion study medication . History , current cerebrovascular disease brain trauma . History , current clinically significant endocrine disorder , e.g . hypo hyperthyroidism , diabetes mellitus . History , current , malignancy . Significant hearing and/or visual impairment may affect ability complete test procedure . Allergy strawberry .</criteria>
	<gender>Female</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Autism</keyword>
	<keyword>Rett 's syndrome</keyword>
	<keyword>Rett disorder</keyword>
	<keyword>Rett 's disorder</keyword>
	<keyword>Ataxia</keyword>
</DOC>